Prescription Drug Supply Chain Pricing Transparency Act

Senate Bill

S. 3751

119th Congress

Prescription Drug Supply Chain Pricing Transparency Act

In Committee

Introduced:Jan 29, 2026

Primary Sponsor

Sponsor information unavailable

Cosponsors

0

Quick Stats

Summary

This bill would require more transparency in how prescription drugs are priced as they move through the supply chain from manufacturers to patients. It aims to make the pricing practices of drug companies, wholesalers, pharmacy benefit managers, and other middlemen more visible to the public and regulators.

Latest Action

Read twice and referred to the Committee on Finance.

Introduced1/29/2026

StatusRead twice and referred to the Committee on Finance.

ChamberSenate

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Prescription Drug Supply Chain Pricing Transparency Act

This bill would require more transparency in how prescription drugs are priced as they move through the supply chain from manufacturers to patients. It aims to make the pricing practices of drug companies, wholesalers, pharmacy benefit managers, and other midd

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would require more transparency in how prescription drugs are priced as they move through the supply chain from manufacturers to patients. It aims to make the pricing practices of drug companies, wholesalers, pharmacy benefit managers, and other middlemen more visible to the public and regulators.

Bill Number: 3751
Introduced: 1/29/2026
Status: Read twice and referred to the Committee on Finance.

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Prescription Drug Supply Chain Pricing Transparency Act
Bill Number: 3751
Sponsor: No sponsor
Status: Read twice and referred to the Committee on Finance.
Introduced: 1/29/2026
Summary: This bill would require more transparency in how prescription drugs are priced as they move through the supply chain from manufacturers to patients. It aims to make the pricing practices of drug companies, wholesalers, pharmacy benefit managers, and other middlemen more visible to the public and reg

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill would require more transparency in how prescription drugs are priced as they move through the supply chain from manufacturers to patients. It aims to make the pricing practices of drug companies, wholesalers, pharmacy benefit managers, and other middlemen more visible to the public and regulators.

Last updated: 2/23/2026

Key Points

Main provisions of the bill

The bill would require companies involved in the prescription drug supply chain to disclose pricing information.
It targets transparency from drug manufacturers, distributors, pharmacy benefit managers, and other entities that handle medications before they reach patients.
The legislation seeks to shed light on how drug prices increase as medications move from production to pharmacy counters.
Increased pricing transparency could help identify where costs are added in the drug distribution process.

How This Impacts Americans

Potential effects on citizens and communities

This bill would affect pharmaceutical companies, drug wholesalers, pharmacy benefit managers, insurers, and other businesses in the prescription drug supply chain by requiring them to share pricing data. Patients and healthcare providers could benefit from better understanding why prescription drugs cost what they do. Policymakers and regulators would gain access to information that could inform future healthcare cost control efforts.

Policy Areas

No policy areas assigned yet.

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

3751, 119th Congress (2026). "Prescription Drug Supply Chain Pricing Transparency Act". Source: Voter's Right Platform. https://votersright.org/bills/119-s-3751

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.